Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-22-010224
Filing Date
2022-04-14
Accepted
2022-04-14 10:18:59
Documents
4
Period of Report
2022-03-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 6977
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 22479
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 557711
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 29008
  Complete submission text file 0001062993-22-010224.txt   617161
Mailing Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6
Business Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6 6048060626
ImmunoPrecise Antibodies Ltd. (Filer) CIK: 0001715925 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: 6-K | Act: 34 | File No.: 001-39530 | Film No.: 22826291
SIC: 2834 Pharmaceutical Preparations